UPDATE: PerkinElmer Revenues Climb 14 Percent in Second Quarter | GenomeWeb

The article has been updated to provide additional information.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that revenues for the second quarter climbed nearly 14 percent, outpacing consensus analyst estimates.

In the three months ended July 4, the company posted revenues of $497.8 million, up from $438.3 million a year ago. Wall Street had expected revenues of $464.7 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."